UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034410
Receipt number R000039240
Scientific Title A phase 2 study of induction chemotherapy followed by chemoradiotherapy for patients with borderline resectable pancreatic cancer
Date of disclosure of the study information 2018/10/10
Last modified on 2019/04/10 17:20:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase 2 study of induction chemotherapy followed by chemoradiotherapy for patients with borderline resectable pancreatic cancer

Acronym

A phase 2 study of induction chemotherapy followed by chemoradiotherapy for patients with borderline resectable pancreatic cancer

Scientific Title

A phase 2 study of induction chemotherapy followed by chemoradiotherapy for patients with borderline resectable pancreatic cancer

Scientific Title:Acronym

A phase 2 study of induction chemotherapy followed by chemoradiotherapy for patients with borderline resectable pancreatic cancer

Region

Japan


Condition

Condition

Pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate that the efficacy of the induction chemotherapy followed by chemoradiotherapy for borderline resectable pancreatic cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

R0 resection rate

Key secondary outcomes

Relapse-free survival
Overall survival
Treatment completion rate
Adverse effect
Pathological response


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

A total of three courses of nab-Paclitaxel and Gemcitabine followed by TS-1 with concurrent radiotherapy of 45Gy for 5 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Histologically proven or radiologically confirmed pancreatic cancer
2) No prior treatment for pancreatic cancer
3) Age between 20 to 85
4) ECOG performance status 0/1
5) White blood cell count above 3000/mm3
Neutrophil count above 1000/mm3
Platelet count above 100000/mm3
Hemoglobin above 8.0 g/dl
Total billirubin below 3.0 mg/dl
AST, ALT below 150 IU/L
Creatinine below 1.5 mg/dl
6) No exclusion criteria
7) Proper informed consent

Key exclusion criteria

1) Contraindication of nab-PTX, GEM, TS-1
2) Pleuritic effusion refractory to diuretics
3) Presence of distant metastasis
4) Presence of concurrent advanced cancer
5) Presence of clinically obvious infection
6) Prior radiotherapy to abdominal lesions
7) Previous history of myocardial infarction within three months
8) Severely mental retardation
9) Current status of pregnancy and lactation, or the possibility of these statuses.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Minoru
Middle name
Last name Kitago

Organization

Keio University School of Medicine

Division name

Department of Surgery

Zip code

1608582

Address

Shinanomachi 35, Shinjuku, Tokyo

TEL

03-3353-1211

Email

dragonpegasus@keio.jp


Public contact

Name of contact person

1st name Minoru
Middle name
Last name Kitago

Organization

Keio University School of Medicine

Division name

Department of Surgery

Zip code

1608582

Address

Shinanomachi 35 Shijuku Tokyo

TEL

0333531211

Homepage URL


Email

dragonpegasus@keio.jp


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Keio University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of Surgery, Tochigi Medical Center
Department of Surgery, Ichikawa General Hospital, Tokyo Dental College
Department of Surgery, Tokyo Medical Center
Department of Surgery, Saitama National Hospital
Department of Surgery, Hiratsuka City Hospital
Department of Surgery, Fussa Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical committee, Keio University

Address

Shinanomachi 35, Shinjuku, Tokyo

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

独立行政法人 国立病院機構 栃木医療センター 外科 (栃木)
東京歯科大学市川総合病院 外科 (千葉)
独立行政法人国立病院機構東京医療センター 外科 (東京)
独立行政法人 国立病院機構 埼玉病院 外科 (埼玉)
平塚市民病院 外科 (神奈川)
公立福生病院 外科 (東京)


Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 10 Month 09 Day

Date of IRB

2019 Year 03 Month 25 Day

Anticipated trial start date

2019 Year 03 Month 25 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 09 Day

Last modified on

2019 Year 04 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039240


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name